California Research Peptides: Storage & COA Guide

California receives more research-peptide shipments than any other US state, and that is a function of its research density rather than its population alone. The University of California system operates ten campuses with five academic medical centres, Stanford sits at the head of the Bay Area cluster, and the independent institutes — the Salk Institute and Scripps Research in La Jolla, the Buck Institute for Research on Aging in Novato, the Gladstone Institutes in San Francisco — form the densest concentration of biomedical laboratories in the country. San Diego's Torrey Pines Mesa and South San Francisco's Oyster Point corridor are the two commercial anchors.

For inbound international parcels, California is effectively three entry points: Los Angeles (LAX), San Francisco (SFO) and, for southern-route freight, Ontario. Which one a kit clears through is decided by the carrier's network, not by the delivery address, so a Sacramento address and a San Diego address can easily clear through different airports and land a day or two apart. That is normal and is not an indication that anything has gone wrong. Every Regena shipment is tracked end to end and carries a research-use declaration in the outer documents pouch; nothing on the catalogue is FDA-approved, and it is supplied for in-vitro laboratory work only.

The state's real handling problem is thermal, not logistical. California spans a Mediterranean coastal strip, an inland valley that regularly exceeds 40 °C in July and August, and desert interior in the southeast. A sealed lyophilised vial is comparatively robust — it is a dry powder under vacuum or inert headspace — but the failure mode we see reported most often is a kit left in an afternoon delivery vehicle or on a shaded-but-hot porch in Sacramento, Fresno, Bakersfield or the Inland Empire. Schedule an attended delivery between June and September and move the kit to 2–8 °C on arrival.

Lyophilised peptide is a freeze-dried cake with a very high surface area, and most sequences on this catalogue are hygroscopic: they pull water out of ambient air the moment the stopper is broken. On the California coast — the fog belt from Monterey through San Francisco, and the marine layer over Los Angeles and San Diego — relative humidity commonly sits above 70% in the morning hours.

The practical rule is that a vial should be opened as few times as possible and never left open on the bench while you prepare a diluent. Water content matters because it drives hydrolysis in storage, and it is the reason a serious certificate of analysis reports a Karl Fischer water figure alongside purity. A batch at low single-digit percent water will behave predictably; a batch with no water figure reported at all is an unknown.

Reconstituted material is a different stability problem. Bacteriostatic water (0.9% benzyl alcohol) supports roughly a 60-day in-use window under refrigeration for most analogues; plain sterile water does not, because it has no preservative. Aliquot before freezing — repeat freeze-thaw cycling is the single most common measurable cause of potency loss in long-acting analogues.

Every Regena kit is ten identical vials drawn from one production batch, so one certificate covers the whole kit. The report should show three independent things. Reverse-phase HPLC gives you the purity number as the area of the main peak relative to total peak area — this is a relative measure, so it tells you what proportion of the material is your target sequence, not how much peptide is in the vial. Mass spectrometry confirms identity by molecular weight, which is what catches a truncated or substituted sequence that HPLC alone can pass. Karl Fischer titration gives water content.

Peptide content assay — sometimes labelled net peptide content — is a fourth figure worth asking for. It is the mass of actual peptide in the vial after counterion salt and residual water are subtracted, and it is the number that determines your working concentration. Purity and content are frequently confused; a 99% pure vial can still be well under its labelled mass if content was never measured.

Independent verification reports are published on the lab reports page and can be checked directly with the testing laboratory at janoshik.com/verify. Reports come from more than one laboratory because different batches originate with different manufacturing partners, and each batch is verified where it is produced.

Buying research peptides in California used to mean importing from undocumented offshore suppliers with no batch-level transparency, opaque domestic re-sellers, or compounding pharmacies priced well above research budgets. Regena replaces those with a verified-batch supply chain: vials originate from manufacturing partners with documented process histories, are tested independently before release, and ship tracked from our European hub to California.

For California laboratories the practical effect is shorter project timelines and cleaner experimental risk. A batch ordered Monday is typically on the bench within the week, with the COA already cross-referenced against the vial cap batch number.

The full Regena catalogue is available for California delivery: GLP-1 agonists (semaglutide, tirzepatide, retatrutide), GH secretagogues (CJC-1295, ipamorelin, tesamorelin, MK-677 reference), regenerative compounds (BPC-157, TB-500, GHK-Cu, KPV) and mitochondrial peptides (MOTS-c, SS-31). Bacteriostatic water, sterile water and mixing supplies can be added to the same order.

Every California shipment includes the printed COA, batch number, lot number and compound-specific reconstitution guidance. Coverage includes Los Angeles, San Francisco, San Diego, San Jose, Sacramento and the Bay Area and the broader California research community.

California orders ship with tracked courier service from our European hub. Standard transit is 5–14 day international; express options are available through the consultations team. Vials travel in temperature-buffered mailers sized for the California transit window so lyophilised product arrives within specification — refrigerate at 2–8 °C on arrival.

Residential laboratory addresses, co-working benches and registered research-entity addresses are all accepted in California. Signature on delivery is the default; safe-place handling is accepted with prior written request.

Every vial dispatched to California ties back to an independent third-party COA hosted on the Regena lab reports page. Janoshik Analytical is the default verifier; orthogonal laboratories are used when batch chemistry calls for second-method confirmation. Minimum specification is ≥99.0% HPLC main-peak purity with matching mass-spectrometry molecular weight.

California researchers should verify three things before reconstitution: the batch number on the vial cap matches the COA, the COA is dated within the shelf-life window, and the storage conditions described on the COA were respected through the courier chain. The /trust/how-to-read-a-coa guide walks through the full checklist.

California hosts an active life-sciences ecosystem including Stanford, UCSF, the UC system, the Salk Institute, the Scripps Research Institute, the Buck Institute and the largest single biotech ecosystem in the United States across the Bay Area and San Diego, and Regena's batch documentation is formatted to slot directly into institutional procurement and ethics processes. MSDS, CoO and CoC documentation is supplied on request before dispatch.

For multi-batch California programmes the consultations team will reserve inventory against a project timeline so a California laboratory is not exposed to the wider catalogue's shifting availability.

Lyophilised peptides delivered to California should be held at 2–8 °C on arrival; long-term storage at −20 °C is appropriate for batches that will not be reconstituted within 8–12 months. Reconstitution with bacteriostatic water (0.9% benzyl alcohol) supports a two-month (60-day) in-use stability window under refrigeration for most analogues.

Aliquot before any freeze; the single most common cause of measurable potency loss in long-acting analogues is repeat freeze-thaw cycling. Vortex gently, never shake aggressively, and keep reconstituted vials away from direct light.

All peptides shipped to California are supplied strictly for in-vitro and preclinical research use. They are not medicines, are not approved for human consumption, and are not dispensed against a prescription. The research-use declaration is included with every California shipment alongside the COA.

Customs handling is pre-cleared from the European hub so California researchers do not face surprise duties or extended border holds. The consultations team will confirm any project-specific documentation question before dispatch.

A free 20-minute consultation is available to every California researcher: compound selection, batch availability, COA review, reconstitution workflow and any project-specific sourcing question. The Regena scientific team takes consultations directly.

Book through the /consultations page; the team responds within one working day across California.